UnitedHealth raises full-year guidance

UnitedHealth Group’s July 16 earnings report gave investors two different data points at once: a strong quarter in the present, and a narrower Medicare footprint ahead. The company reported adjusted earnings of $6.38 a share on $112.0 billion in second-quarter revenue and lifted its full-year 2026 adjusted earnings guidance to $19.50 to $20.00 a share from more than $18.25 previously. (unitedhealthgroup.com) Stephen Hemsley, UnitedHealth’s chief executive, said the updated outlook reflected “continuing progress” as the company simplified operations, redesigned benefits and applied newer technology across the business. (unitedhealthgroup.com) But management also told investors that Medicare Advantage enrollment would decline by roughly 1.1 million this year, underscoring that the margin recovery is coming partly through benefit changes and selective exits rather than broad growth. That combination explains why the stock’s initial jump after earnings did not settle the broader debate. Shares rose nearly 8% in morning trading after the release, but later commentary focused on whether Medicare profitability can hold once the easiest market and product pruning is done. (unitedhealthgroup.com) ### Why did the guidance increase matter so much? UnitedHealth raised its 2026 adjusted earnings forecast to $19.50 to $20.00 a share after posting second-quarter adjusted EPS of $6.38, well above the $4.90 analysts expected, according to LSEG data cited by CNBC. Revenue of $112.03 billion also topped expectations. Wayne DeVeydt, the company’s finance chief, said the quarter reflected product and portfolio actions taken over the past year, along with tighter management disciplines. (unitedhealthgroup.com) The company kept revenue guidance above $439 billion, while DeVeydt told CNBC he expected UnitedHealth to do better than that after the second-quarter beat. ### Where is the improvement actually coming from? The second-quarter release showed the clearest improvement in medical cost management. (marketscreener.com) UnitedHealth’s medical benefit ratio fell to 86.7% from 89.4% a year earlier, which the company tied to benefit redesigns, pricing updates and cost controls. Operating earnings rose to $8.0 billion, and Optum posted $65.7 billion in revenue with $4.0 billion in operating earnings. (cnbc.com) Hemsley said UnitedHealthcare had improved performance in its Medicare businesses through “thoughtful benefit planning and design,” while Optum Health regained momentum and Optum Insight continued investing in AI-enabled tools and services. Reuters reported investors had been waiting for evidence that UnitedHealth could better control medical costs after a difficult stretch for the sector. (cnbc.com) ### Why are investors focused on Medicare Advantage exits? UnitedHealthcare said it expects full-year Medicare Advantage enrollment to decline by about 1.1 million, even as it now expects Medicare margins to finish 2026 above 3%. Management said membership retention was better than previously anticipated, but it also made clear that 2027 bids would remain “disciplined and grounded in the current trend environment.” (finance.yahoo.com) Tim Noel, the head of UnitedHealthcare, said the company would support “program and margin stability” through benefit adjustments and selective changes in market participation. That language matters because it points to a deliberate pullback from business that does not meet return targets, rather than a simple rebound in underlying utilization trends. (unitedhealthgroup.com) ### How much of the story is about AI and administrative costs? CNBC reported that UnitedHealth is investing $1.5 billion in artificial intelligence to streamline operations, with DeVeydt saying the tools are being used to speed prior authorizations, improve payment accuracy and detect fraud, waste and abuse. He also said the tools are not determining whether care is approved or denied. (unitedhealthgroup.com) Hemsley said Optum Insight is positioned to modernize the health system with AI-enabled tools and services. Outside commentary cited by Yahoo Finance argued that UnitedHealth and Elevance could rebuild Medicare margins further through benefit right-sizing and lower administrative costs, though that view came from market analysts rather than company guidance. (unitedhealthgroup.com) ### What should investors watch next? UnitedHealth’s next test is the 2027 Medicare Advantage bid cycle. Management has already said those bids will include benefit adjustments and selective changes in market participation, and the company’s Annual Notice of Change letters to members will show where those decisions land. (cnbc.com) The company’s own targets are now clear for the rest of 2026: adjusted earnings of $19.50 to $20.00 a share, revenue above $439 billion, Medicare Advantage enrollment down about 1.1 million, and Medicare margins above 3% by year-end. (unitedhealthgroup.com 1) (unitedhealthgroup.com 2)